Back
Lexicon Pharmaceuticals, Inc. Vs. Xenon Pharmaceuticals, Inc. Industry Stock Comparison
Sell
36
LXRX
Lexicon Pharmaceuticals, Inc.
Last Price:
$1.59
Seasonality Move:
-4.3%
Buy
62
XENE
Xenon Pharmaceuticals, Inc.
Last Price:
$56.89
Seasonality Move:
4.19%
Sell
36
Lexicon Pharmaceuticals, Inc. (LXRX)
is a Sell
Is Lexicon Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Lexicon Pharmaceuticals, Inc. [LXRX] share price is $1.59. The Score for LXRX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
LXRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Xenon Pharmaceuticals, Inc. (XENE)
is a Buy
Is Xenon Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Xenon Pharmaceuticals, Inc. [XENE] share price is $56.85. The Score for XENE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
XENE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LXRX Stock Price Chart
What is Lexicon Pharmaceuticals, Inc.'s stock price today?
-
The Lexicon Pharmaceuticals, Inc. share price today is $1.59The current trend is relatively stagnant and LXRX is experiencing selling pressure, which indicates risk of future bearish movement.
XENE Stock Price Chart
What is Xenon Pharmaceuticals, Inc.'s stock price today?
-
The Xenon Pharmaceuticals, Inc. share price today is $56.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XENE is experiencing slight buying pressure.
LXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 50.32 | Buy |
| Chaikin Money Flow: | -1387449 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.57 - 1.69) | Sell |
| Bollinger Bands (100): | (1.23 - 1.59) | Buy |
XENE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.54 | Buy |
| Relative Strength Index (14 RSI): | 61.55 | Buy |
| Chaikin Money Flow: | 226752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.95 - 59.27) | Buy |
| Bollinger Bands (100): | (39.35 - 50.85) | Buy |
LXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.62 | Sell |
| 20-day SMA: | 1.64 | Sell |
| 50-day SMA: | 1.52 | Buy |
| 200-day SMA: | 1.3 | Buy |
| 8-day EMA: | 1.53 | Buy |
| 20-day EMA: | 1.13 | Buy |
| 50-day EMA: | 0.61 | Buy |
| 200-day EMA: | 0.18 | Buy |
XENE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.78 | Buy |
| 20-day SMA: | 55.66 | Buy |
| 50-day SMA: | 47.7 | Buy |
| 200-day SMA: | 40.77 | Buy |
| 8-day EMA: | 56.09 | Buy |
| 20-day EMA: | 54.07 | Buy |
| 50-day EMA: | 49.75 | Buy |
| 200-day EMA: | 42.9 | Buy |
Lexicon Pharmaceuticals, Inc. Earnings Growth & LXRX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.03 per share.
Xenon Pharmaceuticals, Inc. Earnings Growth & XENE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.55 per share, and an increase next year of $0.10 per share.
Lexicon Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xenon Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||